Which drug will be partnered first? My money is on
Post# of 72440
"Furthermore, we are receiving significant interest in Brilacidin for inflammatory bowel disease following the successful completion of the Phase 2 proof-of-concept study of Brilacidin for ulcerative proctitis/ulcerative proctosigmoiditis. Ongoing dialogue under confidentiality agreements has us planning for additional studies on that front. "
http://www.ipharminc.com/press-release/2017/9...-agreement
Sounds to me like the additional studies will involve a partner. Today's blog touches on the challenges of different formulations, so I think IPIX needs BP's expertise and technology.
http://www.ipharminc.com/new-blog/2017/9/11/b...ation-work
"This can make drug formulation work, particularly the oral delivery (pdf) of medications , more challenging (e.g., see the FORMAMP Project)."
Interesting read on the FORMAMP Project.
"The FORMAMP project focuses on innovative nanoformulation design of antimicrobial and immunomodulatory peptides in order to increase their efficiency and stability."
http://formampproject.com/about-formamp/formamp-concept/